{{Drugbox
| Watchedfields = changed
| verifiedrevid = 437134954
| IUPAC_name = 2-(4-chlorophenoxy)-''N''-isopropyl-acetohydrazide
| image = Iproclozide.svg

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status = Uncontrolled
| routes_of_administration = Oral

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 3544-35-2
| ATC_prefix = N06
| ATC_suffix = AF06
| PubChem = 19063
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 17998
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = 1II9D6CB3J
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D07338
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 91238

<!--Chemical data-->
| C=11 | H=15 | Cl=1 | N=2 | O=2 
| molecular_weight = 242.70 g/mol
| smiles = Clc1ccc(OCC(=O)NNC(C)C)cc1
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C11H15ClN2O2/c1-8(2)13-14-11(15)7-16-10-5-3-9(12)4-6-10/h3-6,8,13H,7H2,1-2H3,(H,14,15)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = GGECDTUJZOXAAR-UHFFFAOYSA-N
}}

'''Iproclozide''' (trade names '''Sursum''', '''Sinderesin''') is an [[irreversible inhibition|irreversible]] and [[functional selectivity|selective]] [[monoamine oxidase inhibitor]] (MAOI) of the [[hydrazine]] [[chemical class]] that was used as an [[antidepressant]], but has since been [[discontinuation|discontinued]].<ref name="pmid5930723">{{cite journal |vauthors=Suerinck A, Suerinck E | title = [Depressive states in a sanatorium milieu and monoamine oxidase inhibitors. (Therapeutic results by the combination of iproclozide and chlordiazepoxide). Apropos of 146 cases] | journal = Journal de médecine de Lyon | volume = 47 | issue = 96 | pages = 573–586 | year = 1966 | pmid = 5930723 }}</ref> It has been known to cause [[Acute liver failure|fulminant hepatitis]] and there have been at least three reported fatalities due to administration of the drug.<ref name="pmid680506">{{cite journal |vauthors=Pessayre D, de Saint-Louvent P, Degott C, Bernuau J, Rueff B, Benhamou JP | title = Iproclozide fulminant hepatitis. Possible role of enzyme induction. | journal = Gastroenterology. | volume = 75 | issue = 3 | pages = 492–496 | year = 1978 | pmid = 680506 }}</ref><ref name="bookDrug-induced liver disease">{{cite book |author1=Neil Kaplowitz |author2=Laurie D. DeLeve | title = Drug-induced liver disease | publisher = Informa Health Care | year = 2003 | page = 455 | isbn = 0-8247-0811-3 |id={{ISBN|9780824708115}} }}</ref>

== See also ==
* [[Hydrazine (antidepressant)]]

== References ==
{{Reflist|2}}

{{Antidepressants}}
{{Anxiolytics}}
{{Monoamine metabolism modulators}}
{{Hydrazines}}

[[Category:Monoamine oxidase inhibitors]]
[[Category:Withdrawn drugs]]
[[Category:Hepatotoxins]]
[[Category:Hydrazides]]
[[Category:Phenol ethers]]
[[Category:Chloroarenes]]


{{nervous-system-drug-stub}}